Showing results (11-20 of 599) with videos related to
Sort By:
Pageof 60
The Lancet Regional Health. Europe|April 29, 2024
Patient outcomes, efficiency, and adverse events for elective hip and knee replacement in private and NHS hospitals: a population-based cohort study in EnglandMichael Anderson, Rocco Friebel, Laia Maynou, et al.Health Economics|June 28, 2007
If it ain't broke, don't price fix it: the OFT and the PPRSAdrian TowseBritish Journal of Clinical Pharmacology|August 19, 2010
Value based pricing, research and development, and patient access schemes. Will the United Kingdom get it right or wrong?Adrian TowseHealth Policy (Amsterdam, Netherlands)|February 8, 2022
Promoting innovation while controlling cost: The UK's approach to health technology assessmentMichael Anderson, Michael Drummond, David Taylor, et al.BMJ Quality & Safety|April 8, 2022
Evaluation of the NHS England evidence-based interventions programme: a difference-in-difference analysisMichael Anderson, Aoife Molloy, Laia Maynou, et al.The Lancet Regional Health. Europe|August 7, 2023
Challenges and opportunities for incentivising antibiotic research and development in EuropeMichael Anderson, Dimitra Panteli, Robin van Kessel, et al.Journal of Patient-Reported Outcomes|September 22, 2022
Misconceiving patient reported outcome measures (PROMs) as primarily a reporting requirement rather than a quality improvement tool: perceptions of independent healthcare sector stakeholders in the UKMichael Anderson, Emma Pitchforth, Andrew Vallance-Owen, et al.Journal of Epidemiology and Community Health|July 15, 2004
Equity of access to health care: outlining the foundations for actionAdam Oliver, Elias MossialosHealth Policy (Amsterdam, Netherlands)|September 5, 2006
A pricing policy towards the sourcing of cheaper drugs in CyprusSherry Merkur, Elias MossialosPageof 60